Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 260

1.

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.

Wendt M, Gunnarsson I, Bratt J, Bruchfeld A.

Scand J Rheumatol. 2012 Mar;41(2):116-9. doi: 10.3109/03009742.2011.620573. Epub 2011 Nov 28.

PMID:
22118245
[PubMed - indexed for MEDLINE]
2.

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.

Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M.

Nephrol Dial Transplant. 2009 Jan;24(1):179-85. doi: 10.1093/ndt/gfn430. Epub 2008 Aug 6.

PMID:
18685144
[PubMed - indexed for MEDLINE]
Free Article
3.

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.

Eriksson P.

J Intern Med. 2005 Jun;257(6):540-8.

PMID:
15910558
[PubMed - indexed for MEDLINE]
4.

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.

Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.

Rheumatology (Oxford). 2006 Nov;45(11):1432-6. Epub 2006 Apr 21.

PMID:
16632482
[PubMed - indexed for MEDLINE]
Free Article
5.

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Jones RB, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, Savage CO, Jayne DR.

Arthritis Rheum. 2009 Jul;60(7):2156-68. doi: 10.1002/art.24637.

PMID:
19565480
[PubMed - indexed for MEDLINE]
Free Article
6.

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR.

Arthritis Rheum. 2012 Nov;64(11):3760-9. doi: 10.1002/art.34583.

PMID:
22729997
[PubMed - indexed for MEDLINE]
Free Article
7.

Long-term follow-up of different refractory systemic vasculitides treated with rituximab.

Rees F, Yazdani R, Lanyon P.

Clin Rheumatol. 2011 Sep;30(9):1241-5. doi: 10.1007/s10067-011-1756-8. Epub 2011 Apr 27.

PMID:
21523362
[PubMed - indexed for MEDLINE]
8.

Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.

Stassen PM, Tervaert JW, Stegeman CA.

Ann Rheum Dis. 2007 Jun;66(6):798-802. Epub 2006 Dec 19. Review.

PMID:
17179175
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.

Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.

Nephrol Dial Transplant. 2008 Apr;23(4):1307-12. Epub 2007 Dec 8.

PMID:
18065810
[PubMed - indexed for MEDLINE]
Free Article
10.

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Keogh KA, Wylam ME, Stone JH, Specks U.

Arthritis Rheum. 2005 Jan;52(1):262-8.

PMID:
15641078
[PubMed - indexed for MEDLINE]
Free Article
11.

Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.

Pullerits R, Ljevak M, Vikgren J, Bokarewa M.

Scand J Immunol. 2012 Oct;76(4):411-20. doi: 10.1111/j.1365-3083.2012.02747.x.

PMID:
22823472
[PubMed - indexed for MEDLINE]
12.

Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.

Brihaye B, Aouba A, Pagnoux C, Cohen P, Lacassin F, Guillevin L.

Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S23-7.

PMID:
17428359
[PubMed - indexed for MEDLINE]
13.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheum. 2013 Sep;65(9):2441-9. doi: 10.1002/art.38044.

PMID:
23754238
[PubMed - indexed for MEDLINE]
14.

Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases.

Geetha D, Seo P, Specks U, Fervenza FC.

Am J Transplant. 2007 Dec;7(12):2821-5. Epub 2007 Oct 1.

PMID:
17908274
[PubMed - indexed for MEDLINE]
Free Article
15.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.

N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.

PMID:
23902481
[PubMed - indexed for MEDLINE]
Free Article
16.

Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.

Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.

Arthritis Rheum. 2004 Apr 15;51(2):269-73.

PMID:
15077271
[PubMed - indexed for MEDLINE]
Free Article
17.

B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.

Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D.

Clin Otolaryngol. 2009 Aug;34(4):328-35. doi: 10.1111/j.1749-4486.2009.01968.x.

PMID:
19673980
[PubMed - indexed for MEDLINE]
18.

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Thiel J, Hässler F, Salzer U, Voll RE, Venhoff N.

Arthritis Res Ther. 2013 Sep 24;15(5):R133. doi: 10.1186/ar4313.

PMID:
24286362
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.

Waiser J, Budde K, Braasch E, Neumayer HH.

Am J Kidney Dis. 1999 Sep;34(3):e9.

PMID:
10471756
[PubMed - indexed for MEDLINE]
20.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group.

N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905.

PMID:
20647199
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk